Kate Whitaker, APRN
Family · Casper, WYNPI 1114407053
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 81.0% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $614, more than ten times the $51 reported in 2021.
Across 92 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lundbeck LLC$68
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$66
- Pfizer$50
- Novo Nordisk$41
- Bioventus LLC$23
- plus $37 from 2 others
What the payments were for
- Food & beverage$1,502100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 79 | $1,216 |
| Lundbeck LLC | 3 | $68 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $66 |
| Pfizer | 2 | $50 |
| Novo Nordisk | 2 | $41 |
| Bioventus LLC | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,502 in reported general payments places this provider in the 85th percentile of 284 family providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 13 | $14,891 |
| Morphine Sulfate ErMorphine Sulfate | 190 | $5,311 |
| Oxycodone Hcl | 197 | $4,244 |
| Fentanyl | 35 | $3,360 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $2,787 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 53 | $1,765 |
| Tizanidine Hcl | 33 | $1,125 |
| Gabapentin | 70 | $1,014 |
| Pregabalin | 11 | $508 |
| Diclofenac Sodium | 20 | $410 |
| Tramadol Hcl | 18 | $234 |
| Ondansetron Hcl | 17 | $229 |
| Cyclobenzaprine Hcl | 36 | $204 |
| Mirtazapine | 11 | $164 |
| Sertraline Hcl | 24 | $164 |
Paid to pharmacies, not to this prescriber.
Other family in Casper
- Debra GrinerCasper$9K
- Kelly EckesCasper$7K
- Jamie MosbruckerCasper$6K
- Tracie ParsellCasper$4K
- Shawn SnyderCasper$4K
- Anna KnoppCasper$3K
- Brenda ThrelkeldCasper$2K
- Daoreuang KidneyCasper$2K
- Rebecca SambergCasper$2K
- Betty ReynoldsCasper$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.